DGAP-News

Sangui BioTech International Inc.: New expert consensus underlines the outstanding effect of Granulox in chronic wounds

DGAP-News: Sangui BioTech International Inc. / Key word(s): Miscellaneous
Sangui BioTech International Inc.: New expert consensus underlines the
outstanding effect of Granulox in chronic wounds

25.11.2016 / 11:19
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------


Sangui BioTech:
- New expert consensus underlines the outstanding effect of Granulox in
chronic wounds

Witten, November, 25/11/2016:

In the edition 5/2016 of the learned journal
"Wundmanagement" (Wundmanagement 2016; 5: 276-284), the official
notification body of the initiative "Chronische Wunden e.V" (ICW eV), the
"Expert consensus to practical aspects of wound therapy with hemoglobin
spray" has been published. This publication is another proof that the
wound spray Granulox contributes to a faster wound healing.

The recommendation was reconciled by well-known experts from the DACH
region. Which includes Prof. Dr. med. Joachim Dissemond, board member of
ICW e.V. and head of ICW-certified dermatological wound care at the
university hospital in Essen (Germany), Veronika Gerber, first chairman of
ICW e.V., Prof. Dr. Knut Kröger, deputy chairman of ICW e.V. as well as
Kerstin Protz, specialist author and consultant for wound care concepts.

Austria is represented by Prim. Univ. Prof. Dr. med. Robert Strohal and the
wound care manager Peter Kurz. PD Dr. med. Severin Läuchli, acting
president of the European Wound Management Association (EWMA) and head of
dermatology at the University of Zurich and Siegfried Uttenweiler are
responsible for the Swiss vote.

The outstanding contribution not only considers the well-known methods and
possible product combinations of Granulox. It also focuses on the
presentation of the novel M.O.I.S.T concept for the local treatment of
chronic wounds. For the first time, oxygen as well as further substances or
methods with a supporting effect, such as growth factors, are included in
the existing concept for the local therapy of chronic wounds. This is a
milestone for the relevance of oxygen in the area of ​​wound healing. The
expert consensus also shows a clear and precise application algorithm for
Granulox. Accordingly, Granulox should be used every three days for both
acute and chronic wounds which have not decreased by at least 40% after
four weeks of conventional treatment and thus meet the criterion of slowed
wound healing. Healing progress should be reevaluated at 4-week intervals